About the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. Session
Rare cancers such as sarcomas and neuroendocrine tumors present unique challenges due to their low incidence and heterogeneity. Sarcoma research emphasizes the identification of genetic mutations and the development of targeted therapies, including tyrosine kinase inhibitors. Neuroendocrine tumors benefit from advancements in imaging techniques and peptide receptor radionuclide therapy (PRRT), improving precision treatment. Pediatric cancers, though rare, receive focused attention in developing age-appropriate therapies with minimal long-term toxicity. Efforts in international collaborations and funding are crucial to advancing rare cancer research, ensuring improved diagnostics, treatment options, and survivorship care.
Topics Covered in Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers.
Sarcoma Subtyping
Bone Sarcomas
Neuroendocrine Grading
Radionuclide Therapy
Childhood Solid Tumors
Late Toxicity Reduction
Related Scientific Sessions at CIOC 2027
Why Attend the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. Conference 2027 — FAQs
What is the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. track at CIOC 2027?
The Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. sessions?
Cancer researchers and clinicians, educators and students with an interest in Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. are all welcome — whether presenting or attending.
Can I present my research in the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.